CTCVAC

History

2019-SINCE
CTCVAC

Sep, 2024Total 19 Approved veterinary medicine products
Aug, 2022Launched CTCVAC AAA (Low Pathogenic Avian Influenza(LPAI H9N2), Fowl Adenovirus(FAdV), and Avian metapneumovirus(aMPV) killed vaccine)
May, 2022Launched CTCVAC Bac-Dajava (Streptococcus parauberis and Edwardsiella tarda killed vaccine)
Mar, 2022Launched CTCVAC Bac-Dajava Plus (Streptococcus parauberis, Edwardsiella tarda, Vibrio harveyi, and Viral hemorrhagic septicemia virus (VHSV) killed vaccine)
Jan, 2022Approved for FCoV-19 Vac (Canine, Feline SARS-CoV-2 subunit inactivated vaccine)
Sep, 2021Received technology transfer ATOM-Sal L6 (Attenuated Salmonella Typhimurium Live vaccine)
Mar, 2020Approval of CTCVAC FAdV (Fowl Adenovirus Killed Vaccine) and CTCVAC CSF-SE Marker (Classical Swine Fever and Swine Erysipelas Live vaccine)
Nov, 2019Certificated of "Venture Company" from KOSME (Korea SMEs and Startups Agency)
Sep, 2019Established CTCVAC Hong-cheon R&D Center
Jul, 2019Approval of CTCVAC Dajava (The World’s First Killed Vaccine against Scuticociliatosis and Flavobacteriosis for Oliver Flounder)
Apr, 2019Established CTCVAC Inc.

2011-2019
Vaccine Division of
CTCBIO

Mar, 2019Split-off Vaccine Division of CTCBIO : To enhance management decision making and expertise
Nov, 2018Approval of CTCVAC ND (Newcastle disease Live Vaccine)
Apr, 2017Contract for the supply of FAdV vaccines with KCAV-Tianjin Longjinming Technology Co., Ltd.(China) (manufactured by CTCBIO)
Nov, 2016Acquired KVGMP for Biologicals (3 lines: Bacterial, Cell and Egg culture)
Feb, 2015Acquired KVGMP for Biologicals (3 lines: Bacterial, Cell and Egg culture)
Jul, 2014Decided foundation of veterinary vaccine R&D JV ‘KCAV’ with Konkuk University’s Technology Holding Company
Jan, 2011Acquired license for veterinary pharmaceutical manufacture facilities